Iovance Biotherapeutics, Inc. (IOVA)
14.62
+1.31
(+9.84%)
USD |
NASDAQ |
Oct 09, 16:00
14.62
0.00 (0.00%)
After-Hours: 20:00
Iovance Biotherapeutics Max Drawdown (5Y) : 96.84% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 96.84% |
| August 31, 2026 | 96.84% |
| July 31, 2026 | 96.84% |
| June 30, 2026 | 96.84% |
| May 31, 2026 | 96.84% |
| April 30, 2026 | 96.84% |
| March 31, 2026 | 96.84% |
| February 28, 2026 | 96.84% |
| January 31, 2026 | 96.84% |
| December 31, 2025 | 96.84% |
| November 30, 2025 | 96.84% |
| October 31, 2025 | 96.84% |
| September 30, 2025 | 96.84% |
| August 31, 2025 | 96.84% |
| July 31, 2025 | 96.84% |
| June 30, 2025 | 96.84% |
| May 31, 2025 | 96.84% |
| April 30, 2025 | 94.58% |
| March 31, 2025 | 93.72% |
| February 28, 2025 | 93.72% |
| January 31, 2025 | 93.72% |
| December 31, 2024 | 93.72% |
| November 30, 2024 | 93.72% |
| October 31, 2024 | 93.72% |
| September 30, 2024 | 93.72% |
| Date | Value |
|---|---|
| August 31, 2024 | 93.72% |
| July 31, 2024 | 93.72% |
| June 30, 2024 | 93.72% |
| May 31, 2024 | 93.72% |
| April 30, 2024 | 93.72% |
| March 31, 2024 | 93.72% |
| February 29, 2024 | 93.72% |
| January 31, 2024 | 93.72% |
| December 31, 2023 | 93.72% |
| November 30, 2023 | 93.72% |
| October 31, 2023 | 93.72% |
| September 30, 2023 | 91.56% |
| August 31, 2023 | 89.81% |
| July 31, 2023 | 89.81% |
| June 30, 2023 | 89.81% |
| May 31, 2023 | 89.81% |
| April 30, 2023 | 89.81% |
| March 31, 2023 | 89.48% |
| February 28, 2023 | 89.31% |
| January 31, 2023 | 89.31% |
| December 31, 2022 | 89.31% |
| November 30, 2022 | 88.69% |
| October 31, 2022 | 87.87% |
| September 30, 2022 | 87.87% |
| August 31, 2022 | 87.87% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| AVITA Medical, Inc. | 88.49% |
| Halozyme Therapeutics, Inc. | 49.06% |
| Amgen, Inc. | 24.86% |
| CareDx, Inc. | 94.87% |
| Xencor, Inc. | 87.01% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -21.04 |
| Beta (5Y) | 0.7566 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 98.88% |
| Historical Sharpe Ratio (5Y) | -0.1362 |
| Historical Sortino (5Y) | -0.3333 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.60% |